Neonc Technologies Holdings, Inc.

NASDAQ:NTHI

Biotechnology

Healthcare
$4.16 +2.94%

+$0.14 today

Market cap
$120.02M
Beta
0.29
P/E (TTM)
-3.0
EPS (TTM)
-$1.66
52W Low $3.20High $12.99

Volume 0.27M

Average 0.08M

NTHI Stock-Based Compensation

Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.

Neonc Technologies Holdings, Inc.NASDAQ: NTHI

Stock-Based Compensation · Q1 FY2026 · quarter ended Mar 2026

Stock-based compensation declines year over year

Q1 FY2026 stock-based compensation of $2.73M fell 88.2% year over year. Sequentially, it fell 71.5% from the prior quarter.

Context

  • Stock-based compensation amounted to 88909.9% of revenue in FY2025.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$2.73M-71.5% QoQ
Last fiscal yearDec 2025
$35.56M— YoY
LTMMar 2026
$15.21M— YoY
Stock-Based Compensation past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-88.2%——
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Stock-Based Compensation history

USD · from the cash flow

Latest · FY2025
35.56M USD
Year-over-year change
—

Stock-Based Compensation vs competitors

How NTHI compares with its peers on the latest reported figures

No competitor Stock-Based Compensation figures are available to compare.

Neonc Technologies Holdings, Inc.

NASDAQ:NTHI

Intrinsic Alpha fair value

Locked

Current Price

$4.16

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.